Document is current
Any future updates will be listed below
-
Authors
Kohlhase, Konstantin http://orcid.org/0000-0002-1088-9558
Schäfer, Jan Hendrik
Tako, Lisa Marie
Willems, Laurent M.
Hattingen, Elke
Bohmann, Ferdinand O.
Grefkes, Christian
Rosenow, Felix
Strzelczyk, Adam
- License Information
-
More Information
Article History
Received: 5 April 2023
Accepted: 4 May 2023
First Online: 25 May 2023
Declarations
:
: The study was approved by the local ethics committee of the Goethe University Frankfurt (IRB#: 19–285).
: Not applicable.
: KK reports a grant from Merck Serono GmbH. FB reports personal fees and grants from AstraZeneca, Bristol-Myers Squibb (BMS), Boehringer, Laerdal and Stryker. FR reports personal fees from Angelini Pharma, Desitin Arzneimittel, Eisai GmbH, Jazz Pharma, Roche Pharma, UCB Pharma, and Zogenix and grants from the Detlev-Wrobel-Fonds for Epilepsy Research, the Chaja-Foundation Frankfurt, the Deutsche Forschungsgemeinschaft, the LOEWE Programme of the State of Hesse, and the European Union. FR reports, that he is a part of the editorial board of Neurological Research and Practice. AS reports personal fees and grants from Angelini Pharma/Arvelle Therapeutics, Desitin Arzneimittel, Eisai, Jazz (GW) Pharmaceuticals companies, Marinus Pharma, Takeda, UCB, UNEEG medical, and Zogenix. AS reports, that he is a part of the editorial board of Neurological Research and Practice. None of the other authors report conflicts of interest.
